Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients. Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C.. Oncotarget. 2016; 25549-57: p.25549-57. doi:10.18632/oncotarget.8224 10.18632/oncotarget.8224.Article
Oncostat